Imagen de Portada

Weight Loss With GLP ‐1 Agonists in Nondiabetic Adults: Systematic Review and Network Meta‐Analysis

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Michael Lim, Pooja Gokhale, Akwasi Akosah, Lorenzo Villa‐Zapata
Formato:	Artículo Open Access
Publicado:	Wiley 2026
Materias:	Obesity
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

GLP ‐1 Receptor/Dual Agonists for Weight Loss: A Systematic Review and Network Meta‐Analysis of RCTs
por: Jirawan Vienghirun, et al.
Publicado: (2026)

Weight Loss Outcomes Between GLP ‐1 Receptor Agonists and Bariatric Surgery in Adults With Obesity: A Systematic Review, Meta‐Analysis and Meta‐Regression
por: Muhammad Tahir, et al.
Publicado: (2026)

GLP‐1 Receptor Agonists and Weight Loss: A Critical Review of Mechanisms
por: Giorgia Rutigliani, et al.
Publicado: (2026)

Efficacy and Safety of GLP ‐1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMA
por: Binayak Sinha, et al.
Publicado: (2025)

GLP ‐1 Receptor Agonists and Psychiatric Outcomes in Adolescents: A Systematic Review and Meta‐Analysis
por: Cynthia F. X. C. A. Silva, et al.
Publicado: (2026)

Musculoskeletal Outcomes of Glucagon‐Like Peptide‐1 Receptor Agonists Versus Other Antiobesity Agents in Nondiabetic Adults
por: Jie‐Syuan Wu, et al.
Publicado: (2026)

Impact of GLP ‐1 Receptor Agonist Discontinuation on Liver‐Related Parameters: A Systematic Review and Meta‐Analysis
por: Matheus Souza, et al.
Publicado: (2026)

One Year of Exercise After Weight Loss Increases Postprandial GLP ‐1 Secretion in Contrast to Usual Activity or GLP ‐1 Receptor Agonist Treatment
por: Joachim Holt, et al.
Publicado: (2025)

Comparative Efficacy of Metabolic/Bariatric Surgery Versus GLP ‐1 Receptor Agonists: A Network Meta‐Analysis of Randomized Controlled Trials
por: Lucas Sabatella, et al.
Publicado: (2025)

GLP ‐1 Receptor Agonists and Weight Loss Among Suboptimal Responders to Metabolic Bariatric Surgery: A Target Trial Emulation
por: Haisheng Wu, et al.
Publicado: (2026)

RETRACTION : Effects of GLP ‐1 Receptor Agonists on Cognitive Function in Patients With Type 2 Diabetes: A Systematic Review and Meta‐Analysis Based on Randomized Controlled Trials
Publicado: (2026)

Safety of GLP ‐1 and Dual GLP ‐1/ GIP Receptor Agonists in Preconception, Pregnancy, and Lactation: A Systematic Review of Maternal, Fetal, and Neonatal Outcomes
por: Lasin Ozbek, et al.
Publicado: (2026)

Micronutrient and Nutritional Deficiencies Associated With GLP ‐1 Receptor Agonist Therapy: A Narrative Review
por: Jorge Urbina, et al.
Publicado: (2026)

GLP‐1 Receptor Agonists and Substance Use Disorders in Older Adults With Type 2 Diabetes: A Target Trial Emulation
por: Hao Dai, et al.
Publicado: (2025)

Dietary Strategies and Nutritional Management in Patients Receiving GLP ‐1 and Dual GIP / GLP ‐1 Receptor Agonists as Adjuncts to Lifestyle Interventions: A Systematic Review of Randomised Clinical Trials
por: Rayanne Santos de Paulo, et al.
Publicado: (2026)

The Impact of GLP ‐1‐Based Therapies on Cardiovascular Outcomes in Type 2 Diabetes: A Comprehensive Systematic Review and Network Meta‐Analysis
por: Shih‐Ming Chuang, et al.
Publicado: (2026)

Effects of Weight Loss Interventions on Gut Microbiota‐Derived Metabolites Linked to Cardiometabolic Health: A Systematic Review and Meta‐Analysis
por: Fernando Q. Iorra, et al.
Publicado: (2026)

Interpreting Pregnancy Risk After GLP ‐1 Receptor Agonists Discontinuation
por: Roberta Scairati, et al.
Publicado: (2026)

Efficacy and Safety of Tirzepatide on Weight Loss in Patients Without Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
por: Sharath Kommu, et al.
Publicado: (2025)

Weekly Subcutaneous VK2735 , a GIP / GLP ‐1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13‐Week VENTURE Study
por: Harold E. Bays, et al.
Publicado: (2026)

Identifying Social Media‐Based Interactions That Help Adults to Adhere to Weight Loss Goals: A Systematic Review
por: Constanze Betz, et al.
Publicado: (2025)

Interpregnancy Weight Gain and Risks of Perinatal Death: A Systematic Review and Meta‐Analysis
por: Yu Tang, et al.
Publicado: (2025)

Efficacy of Weight‐Lowering Agents on Fat Distribution: A Systematic Review and Network Meta‐Analysis of Randomized Controlled Trials
por: Xiuqi Qiao, et al.
Publicado: (2026)

Association of GLP ‐1 Receptor Agonists With Hepatic Decompensation in the All of Us Research Program
por: Inyoung Hwang, et al.
Publicado: (2026)

The Association of Sarcopenic Obesity With Respiratory Function Outcomes in Adults: A Systematic Review and Meta‐Analysis
por: Tasneem Baabbad, et al.
Publicado: (2026)

Pharmacotherapies for Binge Eating Disorder: Systematic Review and Network Meta‐Analysis
por: Gabriel P. A. Costa, et al.
Publicado: (2025)

Association of Glucagon‐Like Peptide‐1 Receptor Agonist Use With Risk of Psychiatric Disorders: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
por: Shumeng Han, et al.
Publicado: (2026)

Association of Glucagon‐Like Peptide‐1 Receptor Agonists and Suicidality: A Systematic Review
por: Hezekiah C. T. Au, et al.
Publicado: (2026)

GLP‐1 Receptor Agonist Medications for Obesity and Type 2 Diabetes Treatment: A Rapid Review of Changes in Eating Behaviors and Eating Disorder Risk
por: Hiba Jebeile, et al.
Publicado: (2025)

Effect of Behavioral Weight Management Interventions on Symptoms of Binge‐Eating Disorder and Bulimia Nervosa: A Systematic Review and Meta‐Analysis
por: Michael P. Berry, et al.
Publicado: (2026)

Association Between Glucagon‐Like Peptide‐1 Receptor Agonists and Suicidality: A Systematic Review
por: Timothy H. Chan, et al.
Publicado: (2026)

Combining GLP ‐1 Receptor Agonists and Health‐Behaviour and Lifestyle Therapy Yields Higher Adherence and Reduces Session Needs for Successful Weight Management in Adolescence: An Observational Real‐World Single‐Center Study
por: Julia Lischka, et al.
Publicado: (2026)

Effect of Clinically Significant Weight Loss on Remission of Metabolic Complications: A Rapid Review and Meta‐Analysis of Comparative Controlled Studies
por: Srividya Adapa, et al.
Publicado: (2026)

Exploring the Relationship Between Obesity, Weight Loss and Health‐Related Quality of Life: An Updated Systematic Review of Reviews
por: Tone Nygaard Flølo, et al.
Publicado: (2025)

Weight Loss, Obesity Medication, and Risk of Obesity‐Associated Cancer: A Meta‐Analysis of Randomized Controlled Trials
por: Chengwen Li, et al.
Publicado: (2025)

GLP‐1 RA Use and Weight Loss Among Patients in a Weight Navigation Program Versus Primary Care: A Matched Cohort Study
por: Dina H. Griauzde, et al.
Publicado: (2026)

Effects of Moderate‐Frequency Resistance Training on Cardiometabolic Risk Factors in Adults With Overweight or Obesity: A Systematic Review and Meta‐Analysis
por: Yigao Wu, et al.
Publicado: (2026)

The Effect of Behavioral Sleep Interventions on Measures of Obesity, Dietary Intake and Physical Activity in Adults With Poor Sleep Health: A Systematic Review, Meta‐Analysis and Meta‐Regression Analysis
por: Samiul A. Mostafa, et al.
Publicado: (2026)

Optimizing Obesity Management With GLP‐1 Agonist Medication Through Mobile Health Technology, Nutrition Therapy, and Progressive Strength Training: A Retrospective Program Review
por: Elizabeth Sharp Edens, et al.
Publicado: (2026)

Beyond GLP ‐1 Monotherapy: Novel Multi‐Agonists, Amylin Analogues, and Combination Strategies in Obesity and Type 2 Diabetes
por: Mikhail Khachaturov, et al.
Publicado: (2026)